Cephagenix

Glostrup, Denmark

Cephagenix focuses on identifying and developing new, effective migraine therapies.

$9.3M raised

Jan 2025

Seed

Top Investors

AbbVieAdBio partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cephagenix raised?

Cephagenix has raised $9.3M in total funding. The most recent round was Seed. The last funding was announced in January 2025.

Who are Cephagenix's investors?

Cephagenix's investors include AbbVie, AdBio partners.

Where is Cephagenix headquartered?

Cephagenix is headquartered in Glostrup, Denmark.

What does Cephagenix do?

Cephagenix focuses on identifying and developing new, effective migraine therapies.

What stage is Cephagenix at?

Cephagenix is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 16, 2025.

MLA

"Cephagenix — Funding & Investors." VCBacked, January 16, 2025, https://www.vcbacked.co/company/cephagenix. Accessed June 17, 2026.

APA

VCBacked. (2025). Cephagenix — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/cephagenix

Wikipedia (cite web)

{{cite web |title=Cephagenix — Funding & Investors |url=https://www.vcbacked.co/company/cephagenix |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 16, 2025.